Eurecat present paper at IFHN-2024 congress exploring fibromyalgia drug interactions with DAO
We are happy to share that the presentation by our esteemed partner, Eurecat, titled "Exploring the Relationship Between Diamine Oxidase and Psychotropic Medications in Fibromyalgia Treatment" was very well received at the IFHN-2024 congress, held on June 26-27, 2024, in Prague, Czech Republic. The insightful discussion sparked significant interest and engagement among attendees, reflecting the importance and relevance of this research in advancing fibromyalgia treatment.
The event provided an incredible platform for exchanging knowledge and insights, and we were thrilled to see such a positive response from the audience.
For those who couldn't attend or wish to delve deeper into the topic, the paper presented at the congress is available for download. Don't miss this opportunity to explore the groundbreaking findings and contribute to the ongoing conversation in this critical field.
